CSS
RNAM

Cubist Systematic Strategies’s Avidity Biosciences RNAM Stock Holding History

Cubist Systematic Strategies’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-156,145
Closed -$996K – 4028
2023
Q3 		$996K Buy
+156,145
New +$1.35M 0.01% 1889
2023
Q1 		– Sell
-129,089
Closed -$2.86M – 4341
2022
Q4 		$2.86M Buy
129,089
+117,954
+1,059% +$1.76M 0.02% 1512
2022
Q3 		$182K Buy
+11,135
New +$213K ﹤0.01% 3818
2022
Q1 		– Sell
-11,401
Closed -$271K – 3739
2021
Q4 		$271K Sell
11,401
-4,127
-27% -$98.6K ﹤0.01% 2866
2021
Q3 		$382K Buy
+15,528
New +$338K ﹤0.01% 2206
2021
Q2 		– Sell
-13,415
Closed -$293K – 3071
2021
Q1 		$293K Buy
+13,415
New +$328K ﹤0.01% 2266

Other funds holding RNAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Cubist Systematic Strategies's RNAM Position: Q4 2023 in Review

Cubist Systematic Strategies sold out of Avidity Biosciences (RNAM) in Q4 2023, closing a stake of 156,145 shares — an estimated $996K sold.

Cubist Systematic Strategies first reported a position in RNAM in Q1 2021 and held it in 6 quarters. The position peaked at $2.86M in Q4 2022. 144 funds tracked by Wall St. Rank hold RNAM as of Q4 2023.

  • Cubist Systematic Strategies reported no remaining Avidity Biosciences position as of Q4 2023 after selling out during the quarter.
  • Cubist Systematic Strategies sold 156,145 Avidity Biosciences shares in Q4 2023, an estimated $996K.
  • Cubist Systematic Strategies first reported a position in Avidity Biosciences in Q1 2021 and held it in 6 quarters.
  • Cubist Systematic Strategies's Avidity Biosciences position peaked at $2.86M in Q4 2022.
  • 144 funds tracked by Wall St. Rank held Avidity Biosciences as of Q4 2023.

Based on Cubist Systematic Strategies's 13F filing for Q4 2023, filed 14 Feb 2024.